The U.S. government has struck a $1.95 billion deal with American pharmaceutical company Pfizer and German biotechnology company BioNTech for 100 million COVID-19 vaccine doses.
Latest News
The U.S. government has struck a $1.95 billion deal with American pharmaceutical company Pfizer and German biotechnology company BioNTech for 100 million COVID-19 vaccine doses.